Show simple item record

dc.contributor.authorRepschlaeger, Cen_US
dc.contributor.authorOdabashian, Men_US
dc.contributor.authorSpada, Fen_US
dc.contributor.authorAlmutairi, Zen_US
dc.contributor.authorGribben, JGen_US
dc.contributor.authorForconi, Fen_US
dc.contributor.authorSayan, Een_US
dc.contributor.authorAlves, ACen_US
dc.contributor.authorGiroud, Cen_US
dc.contributor.authorFedorov, Oen_US
dc.contributor.authorKriajevskaia, Men_US
dc.contributor.authorKrysov, Sen_US
dc.date.accessioned2023-03-14T09:38:05Z
dc.date.issued2022en_US
dc.identifier.issn0006-4971en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/84962
dc.format.extent12375 - 12376en_US
dc.titleEMT-like Activation in CLL Provides Novel Therapeutic Targeten_US
dc.typeConference Proceeding
dc.identifier.doi10.1182/blood-2022-162696en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000893230305197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume140en_US
qmul.funderA novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leukaen_US
qmul.funderA novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leukaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record